Lilly's Sepsis Drug Draws FDA Scrutiny

Updated from 3:35 p.m. EST

The good cheer aroused by Eli Lilly's(LLY Quote) blood thinner prasugrel was tempered somewhat Wednesday by a report that the FDA was investigating an increased incidence of bleeding in another of the company's drugs, Xigris.

The Food and Drug Administration said Wednesday that a retrospective, 73-patient study of Lilly's Xigris, which is used to treat patients with sepsis, a type of blood poisoning, showed an increased the risk of internal bleeding in those with a recent history of hemorrhages.

...